유방암 환자의 혈액 및 암조직에서 생물학적 치료의 Target으로서 Urokinase-type Plasminogen Activator (uPA) Receptor, Plasminogen Activator Inhibitor-1 의발현
= "Clinical Relevance of Urokinase0type Plasminogen Activator (uPA), uPA Receptor, Plasminogen Activator Inhibitor-1 Co-expression from Tissue and Serum of Breast Cancer as Targets of Biotherapy"